A new imaging approach being investigated by Memorial Sloan-Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.

Memorial Sloan-Kettering physician-scientist Charles Sawyers, who serves as president of the American Association for Cancer Research, highlights findings from the group’s new report.

Memorial Sloan-Kettering clinicians report on a successful first year of using a new procedure to pinpoint and remove small breast cancers.

A recent study found that the cell lines most commonly used for research on ovarian cancer are not the most suitable.

An international study led by Memorial Sloan-Kettering found that pazopanib (Votrient^®) controls cancer as effectively as sunitinib (Sutent^®) while improving patients’ quality of life.

Information about the microbiome, the genes of all the microorganisms that naturally inhabit the human body, is leading to new approaches for treating infections in cancer patients.

The clinical trial remains our best tool to identify new therapies, but as with all tools, innovation is required if trials are to remain relevant.